Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Bladder cancer is one of the most common and highly vascularized cancers. Here the authors perform a whole-genome analysis in urothelial bladder carcinomas and identify recurrent genetic alterations in a set of angiogenesis genes, facilitating the understanding of molecular mechanisms underlying pat...
Main Authors: | Song Wu, Tong Ou, Nianzeng Xing, Jiang Lu, Shengqing Wan, Changxi Wang, Xi Zhang, Feiya Yang, Yi Huang, Zhiming Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-08576-5 |
Similar Items
-
Role and expression of FRS2 and FRS3 in prostate cancer
by: Valencia Tania, et al.
Published: (2011-11-01) -
GPR56/ADGRG1 is associated with response to antidepressant treatment
by: Raoul Belzeaux, et al.
Published: (2020-04-01) -
LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
by: Tao Jiang, et al.
Published: (2020-10-01) -
The Activation and Signaling Mechanisms of GPR56/ADGRG1 in Melanoma Cell
by: Kuan-Yeh Huang, et al.
Published: (2018-08-01) -
GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma
by: Marta Moreno, et al.
Published: (2017-11-01)